The global Transurethral Prostatic Resection Device market size is predicted to grow from US$ 1383 million in 2025 to US$ 1895 million in 2031; it is expected to grow at a CAGR of 5.4% from 2025 to 2031.
A transurethral resection of the prostate (TURP) is a surgical procedure that involves cutting away a section of the prostate. The prostate is a small gland in the pelvis only found in men. It is located between the penis and bladder and surrounds the urethra (the tube that carries urine from the bladder to the penis).
Market Overview: The transurethral prostatic resection device market has witnessed significant growth due to the increasing prevalence of BPH and the rising demand for minimally invasive treatment options. TURP is a widely accepted and effective procedure for relieving urinary symptoms associated with BPH, and the demand for TURP devices is driven by the growing patient population and advancements in technology.
Key Features:
- Procedure and Device
- Market Dynamics
- Market Players
- Regulatory Landscape
- Market Outlook
Segmentation by Type:
- Monopolar TURP
- Bipolar TURP
Segmentation by Application:
- Benign Prostate Hyperplasia
- Urinary Tract Infection
- Erectile Dysfunction
- Others
Market by Region:
- Americas
- APAC
- Europe
- Middle East & Africa
Company's Coverage:
- Wellspect HealthCare
- Manfred Sauer
- Teleflex
- Hollister
- Boston Scientific
- Karl Storz
- Olympus
- Lumenis
- Covidien
- Cook Medical
Key Questions Addressed in this Report:
- What are the key trends in the market?
- What are the growth opportunities in the market?
- What are the major challenges faced by the market?
- Who are the key players in the market and what are their strategies?
Frequently Asked Questions
What is the USP of the report? expand_more
What are the key content of the report? expand_more
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market